The use of selected sulfhydryl inhibitors in a preferential drug attack on cancer

Surg Gynecol Obstet. 1971 Sep;133(3):458-66.
No abstract available

MeSH terms

  • Adenocarcinoma / drug therapy
  • Adenocarcinoma / metabolism
  • Adult
  • Agar
  • Animals
  • Antineoplastic Agents / therapeutic use*
  • Anus Neoplasms / drug therapy
  • Anus Neoplasms / metabolism
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / metabolism
  • Carcinoma, Squamous Cell / drug therapy
  • Carcinoma, Squamous Cell / metabolism
  • DNA / metabolism
  • Dogs
  • Humans
  • Leucine
  • Leukocytes / metabolism
  • Liver / metabolism
  • Mice
  • Middle Aged
  • Neoplasms / drug therapy*
  • Neoplasms, Experimental / drug therapy
  • Neoplasms, Experimental / metabolism
  • Parotid Neoplasms / drug therapy
  • Parotid Neoplasms / metabolism
  • Proteins / metabolism
  • RNA / metabolism
  • Radioisotopes
  • Rectal Neoplasms / drug therapy
  • Rectal Neoplasms / metabolism
  • Sulfhydryl Compounds / antagonists & inhibitors*
  • Thoracic Neoplasms / drug therapy
  • Thoracic Neoplasms / metabolism
  • Thymidine
  • Uridine

Substances

  • Antineoplastic Agents
  • Proteins
  • Radioisotopes
  • Sulfhydryl Compounds
  • RNA
  • Agar
  • DNA
  • Leucine
  • Thymidine
  • Uridine